Document:

EX-10.2 Registration Rights Agreement

 

Exhibit 10.2

REGISTRATION RIGHTS AGREEMENT

     This Registration Rights Agreement (the “Agreement”) is made and entered into as of June 19,
2007 by and between 3D Systems Corporation, a Delaware corporation (the “Company”), and each of the
purchasers of its Common Stock (as defined below) pursuant to a Securities Purchase Agreement dated
as of the date hereof (each, an “Investor” and collectively, the “Investors”). Capitalized terms
used and not defined herein shall have the respective meanings ascribed to them in the Securities
Purchase Agreements.

     WHEREAS, the Company has sold 1,250,000 shares (the “Shares”) of its common stock, par value
$0.001 per share, (the “Common Stock”), to the Investors in a private placement (the “Offering”);
and

     WHEREAS, the execution and delivery of this Agreement by the Company is a condition to the
completion of the Offering.

     NOW, THEREFORE, the parties hereto agree as follows:

     1. Registration Procedures and Expenses. The Company shall:

          (a) use its commercially reasonable efforts to prepare and file with the Securities and
Exchange Commission (“SEC”), within ninety (90) calendar days after the Closing Date, a
Registration Statement on Form S-1, or on such other form as is available to the Company, to enable
the resale of the Shares by the Investors from time to time;

          (b) use its commercially reasonable efforts to cause the Registration Statement to become
effective, (i) in the event the Registration Statement is not reviewed by the SEC, as promptly as
reasonably practicable after receipt of notice from the SEC that the Registration Statement is
subject to a “no review,” or (ii) in the event the Registration Statement is reviewed by the SEC,
as soon as reasonably practicable after the satisfactory resolution or clearance of any comments
received from the SEC relating to the Registration Statement;

          (c) use its commercially reasonable efforts to prepare and file with the SEC such amendments
and supplements to the Registration Statement and the Prospectus as may be necessary to keep the
Registration Statement current and effective (including any amendment necessary to convert the
Registration Statement from a Form S-1 to a Form S-3) and so that such Registration Statement will
not contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading for a period ending on
the earlier of (i) the second anniversary of the Closing Date; (ii) the date on which the Investors
may sell the Shares held by the Investors without restriction by the volume limitations of Rule
144(e) under the Securities Act; or (iii) such time as all Shares purchased by the Investors in
this Offering have been sold (A) pursuant to a registration statement, (B) to or through a broker,
dealer or underwriter in a public distribution or a public securities transaction, or (C) in a
transaction exempt from the registration and prospectus delivery requirements of the Securities Act
under Section 4(1) thereof so that all transfer

 

 

restrictions and restrictive legends with respect thereto, if any, are removed upon the
consummation of such sale;

          (d) notify the Investors as promptly as reasonably practicable (and if requested confirm such
notice in writing) following (i) the SEC’s notifing the Company whether there will be a “review” of
a Registration Statement and the SEC’s issuance of comments in writing on such Registration
Statement (and upon request by an Investor, the Company shall provide the Investor true and
complete copies of any such SEC comment letter and all written responses thereto); (ii) with
respect to a Registration Statement or any post-effective amendment, when the same has become
effective; (iii) any request by the SEC for amendments or supplements to a Registration Statement
or Prospectus or for additional information; (iv) the issuance by the SEC of any stop order
suspending the effectiveness of a Registration Statement covering any or all of the Shares or the
initiation of any proceedings for that purpose; (v) the receipt by the Company of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the
Shares for sale in any jurisdiction, or the initiation or threatening of any proceeding for such
purpose; and (vi) the occurrence of any event or passage of time that makes the financial
statements included in a Registration Statement ineligible for inclusion therein or any statement
made in such Registration Statement or Prospectus or any document incorporated or deemed to be
incorporated therein by reference untrue in any material respect or that requires any revisions to
such Registration Statement, Prospectus or other documents so that they will not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading;

          (e) when eligible to use Form S-3, file a post-effective amendment to the Registration
Statement to convert it to Form S-3 and use its commercially reasonable efforts to cause the
post-effective amendment to the Registration Statement to become effective as soon as reasonably
practicable after the filing of the amendment;

          (f) furnish to each Investor such number of copies (in paper or electronic version) of the
Registration Statement and the Prospectus (including each amendment and supplement thereto), as
such Investor may reasonably request, in order to facilitate the public sale or other disposition
of all or any of the Shares by the Investor;

          (g) file documents required of the Company for normal blue sky clearance in states specified
in writing by the Investors; provided, however, that the Company shall not be required to qualify
to do business or consent to service of process in any jurisdiction in which it is not now so
qualified or has not so consented;

          (h) bear all expenses (other than underwriting discounts and commissions, if any, and any
expenses of counsel to any Investor) in connection with the procedures in paragraph (a) through (e)
of this Section 1 and the registration of the Shares pursuant to the Registration Statement;

          (i) with a view to making available to the Investors the benefits of Rule 144 or other rule
that may permit the Investors to sell Shares without registration, the Company agrees to use its
commercially reasonable efforts to: (i) make and keep public information

2

 

available, as those terms are understood and defined in Rule 144, until the earlier of (A) such
date as all of the Investors’ Shares may be resold pursuant to Rule 144 or (B) such date as all of
the Investors’ Shares shall have been sold; (ii) file with the SEC all reports and other documents
required of the Company under the Securities Act and under the Exchange Act; and (iii) furnish to
each Investor upon request when appropriate to do so (A) a written statement that the Company has
complied with the reporting requirements of the Securities Act and the Exchange Act, (B) a copy (in
paper or electronic version) of the Company’s most recent Annual Report on Form 10-K or Quarterly
Report on Form 10-Q, and (C) such other information as may be reasonably requested that permits the
selling of any such Shares without registration; and

          (j) cause all such Shares registered pursuant hereto to be listed on Nasdaq and each
other securities exchange on which similar securities issued by the Company are then listed.

          It shall be a condition precedent to the obligations of the Company to take any action
pursuant to this Section 1 with respect to an Investor, that such Investor shall furnish to the
Company such information and representations regarding the Investor and the Shares to be sold by
the Investor as shall be required to effect the registration of the Shares and/or sale under Rule
144, including the information and representations required by the Confidential Investor
Questionnaire and the Selling Stockholder Questionnaire.

     2. Transfer of Shares After Registration; Suspension.

          (a) Each Investor agrees that it will not effect any disposition or other transfer of the
Shares that would constitute a sale within the meaning of the Securities Act other than
transactions exempt from the registration requirements of the Securities Act or pursuant to, and as
contemplated in, the Registration Statement and as described below, and that it will promptly
notify the Company of any changes in the information set forth in the Registration Statement
regarding the Investor or its plan of distribution.

          (b) Except in the event that paragraph (c) below applies, the Company shall: (i) if deemed
necessary by the Company, prepare and file from time to time with the SEC a post-effective
amendment to the Registration Statement or a supplement to the related Prospectus or a supplement
or amendment to any document incorporated therein by reference or file any other required document
so that such Registration Statement will not contain an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein
not misleading, and so that, as thereafter delivered to purchasers of the Shares being sold
thereunder, such Prospectus will not contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading; (ii) provide each Investor
with either copies of any documents filed pursuant to Section 2(b)(i) or access to such documents
electronically; and (iii) upon request, inform each Investor who so requests that the Company has
complied with its obligations in Section 2(b)(i) (or that, if the Company has filed a
post-effective amendment to the Registration Statement which has not yet been declared effective,
the Company will notify each Investor to that effect, will use its commercially reasonable efforts
to secure the effectiveness of such post-effective amendment as promptly as possible and will
promptly notify each Investor pursuant to Section 2(b)(i) hereof when the amendment has become
effective).

3

 

          (c) Subject to paragraph (e) below, in the event: (i) of any request by the SEC or any other
federal or state governmental authority during the period of effectiveness of the Registration
Statement for amendments or supplements to the Registration Statement or related Prospectus or for
additional information; (ii) of the issuance by the SEC or any other federal or state governmental
authority of any stop order suspending the effectiveness of the Registration Statement or the
initiation of any proceedings for that purpose; (iii) of the receipt by the Company of any
notification with respect to the suspension of the qualification or exemption from qualification of
any of the Shares for sale in any jurisdiction or the initiation of any proceeding for such
purpose; (iv) the Company determines in good faith, based on the advice of counsel, that (A) the
offer or sale of Shares covered by the Registration Statement would require disclosure of material
non-public information not otherwise required to be disclosed under applicable law (including,
without limitation, the occurrence or existence of a proposed or pending acquisition, merger or
other material corporate development) and (B) the Company has a bona fide business purpose for
preserving the confidentiality of such information, or (v) of any event or circumstance which
necessitates the making of any material changes in the Registration Statement or Prospectus, or any
document incorporated or deemed to be incorporated therein by reference, so that, in the case of
the Registration Statement, it will not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not
misleading, and that in the case of the Prospectus, it will not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; then the Company shall promptly deliver a certificate in writing or electronically to
each Investor (the “Suspension Notice”) to the effect of the foregoing and, upon receipt of such
Suspension Notice, each Investor will refrain from selling any Shares pursuant to the Registration
Statement (a “Suspension”) until such Investor is advised in writing by the Company that the
current Prospectus may be used, and has received copies of any additional or supplemental filings
that are incorporated or deemed incorporated by reference in any such Prospectus. Each Investor
covenants that from the date hereof it will maintain in confidence the receipt and content of any
Suspension Notice provided in accordance with this paragraph (c) and that, during the period of
time in which the Suspension Notice is in effect, neither it nor any of its affiliates will engage
in any transactions involving the securities of the Company. In the event of any Suspension, the
Company will use its commercially reasonable efforts to cause the use of the Prospectus so
suspended to be resumed as soon as reasonably practicable but in any event within ninety (90) days
after delivery of a Suspension Notice to Investors. In addition to, and without limiting any other
remedies (including, without limitation, at law or at equity) available to the Investors or the
Company, the Investors and the Company shall be entitled to specific performance in the event that
the other party fails to comply with the provisions of this Section 2(c).

          (d) Notwithstanding the foregoing paragraphs of this Section 2, the Investors shall not be
prohibited from selling any Shares under the Registration Statement as a result of Suspensions on
more than two occasions of not more than ninety (90) days each and not more than one hundred eighty
(180) days in the aggregate in any twelve month period.

          (e) If a Suspension is not then in effect, the Investors may sell Shares under the
Registration Statement, provided that they comply with any applicable prospectus delivery
requirements.

4

 

     3. Indemnification. For the purpose of this Section 3:

          (a) the term “Selling Shareholder” shall mean the Investor and each person, if any, who
controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act;

          (b) the term “Registration Statement” shall mean any final Prospectus, exhibit, supplement or
amendment to, and any document incorporated by reference in, the applicable Registration Statement
(or deemed to be a part thereof) referred to in Section 1; and

          (c) the term “untrue statement” shall mean any material untrue statement, or any material
omission of a statement of a material fact required to be made in the Registration Statement or
necessary to make the statements in the Registration Statement, in the light of the circumstances
under which they were made, not materially misleading.

          (d)   (i)   The Company agrees to indemnify and hold harmless each Selling Shareholder from and
against any losses, claims, damages or liabilities (collectively, “Losses”) to which such Selling
Shareholder may become subject (under the Securities Act or otherwise) insofar as such Losses (or
actions or proceedings in respect thereof) arise out of, or are based upon any untrue statement
contained in the Registration Statement. The Company will reimburse such Selling Shareholder for
any reasonable legal expense incurred or any out of pocket expenses reasonably incurred in
defending any such claim, action or proceeding; provided, however, that the Company shall not be
liable in any such case to the extent that such Losses arise out of, or are based upon, (i) any
untrue statement made in such Registration Statement in reliance upon and in conformity with
written information furnished to the Company by or on behalf of such Selling Shareholder for use in
preparation of the Registration Statement, (ii) any inaccuracy in the representations made by such
Selling Shareholder in the Confidential Investor Questionnaire or Selling Stockholder Questionnaire
or (iii) any untrue statement in any Prospectus that is corrected in any subsequent Prospectus that
was delivered to the Selling Shareholder prior to the pertinent sale or sales by the Selling
Shareholder.

               (ii) Each Investor agrees, severally and not jointly, to indemnify and hold harmless the
Company (and each person, if any, who controls the Company within the meaning of Section 15 of the
Securities Act, each officer of the Company who signs the Registration Statement and each director
of the Company) from and against any Losses to which the Company (or any such officer, director or
controlling person) may become subject (under the Securities Act or otherwise), insofar as such
Losses (or actions or proceedings in respect thereof) arise out of, or are based upon, (i) any
untrue statement contained in the Registration Statement if, and only if, such untrue statement was
made in reliance upon and in conformity with written information furnished by or on behalf of the
Investor for use in preparation of the Registration Statement, (ii) any inaccuracy in
representations made by the Investor in the Confidential Investor Questionnaire or Selling
Stockholder Questionnaire or (iii) any untrue statement in any Prospectus that is corrected in any
subsequent Prospectus that was delivered to the Investor prior to the pertinent sale or sales by
the Investor. Each Investor will reimburse the Company (or such

5

 

officer, director or controlling person), as the case may be, for any reasonable legal expense
incurred or any out of pocket expenses reasonably incurred in defending any such claim, action or
proceeding. The obligation of each Investor to indemnify shall be limited to the net amount of the
proceeds received by such Investor from the sale of Shares pursuant to the Registration Statement.

               (iii) Promptly after receipt by any indemnified person of a notice of a claim or the beginning
of any action in respect of which indemnity is to be sought against an indemnifying person pursuant
to this Section 3, such indemnified person shall notify the indemnifying person in writing of such
claim or of the commencement of such action, but the omission to so notify the indemnifying person
will not relieve it from any liability which it may have to any indemnified person under this
Section 3 (except to the extent that such omission adversely affects the indemnifying person’s
ability to defend such action) or from any liability otherwise than under this Section 3. Subject
to the provisions hereinafter stated, in case any such action shall be brought against an
indemnified person, the indemnifying person shall be entitled to participate therein, and, to the
extent that it shall elect by written notice delivered to the indemnified person promptly after
receiving the aforesaid notice from such indemnified person, shall be entitled to assume the
defense thereof, with counsel reasonably satisfactory to such indemnified person. After notice
from the indemnifying person to such indemnified person of its election to assume the defense
thereof (unless it has failed to assume the defense thereof and appoint counsel reasonably
satisfactory to the indemnified person), such indemnifying person shall not be liable to such
indemnified person for any legal expenses subsequently incurred by such indemnified person in
connection with the defense thereof except as set forth below. Notwithstanding such indemnifying
person’s election to assume the defense of any such action, the indemnified persons shall have the
right to employ only a single firm of separate counsel (plus one local counsel in any jurisdiction
in which an action is pending for which indemnified persons are seeking indemnity) and to
participate in the defense of such claim at their own expense; provided that the indemnifying
person shall bear the reasonable fees, costs and expenses of such separate counsel if (i) the use
of counsel chosen by the indemnifying person to represent the indemnified persons would, in the
reasonable opinion of such counsel, present such counsel with a conflict of interest; (ii) the
actual or potential defendants in, or targets of, any such action include both the indemnifying
person and the indemnified persons and the indemnified persons shall have reasonably concluded that
there may be legal defenses available to the indemnified persons which are different from or
additional to those available to the indemnifying person (in which case the indemnifying person
shall not have the right to assume the defense of such claim on behalf of the indemnified persons);
(iii) the indemnifying person shall not have employed counsel reasonably satisfactory to the
indemnified persons to represent the indemnified persons within a reasonable time after notice of
the institution of such claim; or (iv) the indemnifying person shall authorize the indemnified
persons to employ separate counsel at the indemnifying person’s expense. However, the indemnifying
person shall not be liable for the expenses of more than one firm of separate counsel (plus one
local counsel in any jurisdiction in which an action is pending for which indemnified persons are
seeking indemnity) selected by the indemnified persons in any single claim or proceeding for all of
the indemnified persons unless the indemnifying person consents or unless a bona fide conflict of
interest requires separate counsel for particular indemnified persons. The indemnifying person
will not, without the indemnified persons’ prior written consent, settle, compromise, consent to
the entry of any

6

 

judgment in or otherwise seek to terminate any threatened or pending action, claim, suit,
investigation or proceeding in respect of which indemnification may be sought hereunder (whether or
not any indemnified person is a party thereto) unless such settlement, compromise, consent or
termination includes a full, final and unconditional release of each indemnified person from any
and all liabilities related to or arising out of such threatened or pending action, claim, suit,
investigation or proceeding. The indemnifying person will not permit any such settlement,
compromise, consent or termination to include a statement as to, or an admission of, fault,
culpability or a failure to act by or on behalf of an indemnified person, without such indemnified
person’s prior written consent. No indemnified person seeking indemnification, reimbursement or
contribution under this agreement will, without the indemnifying person’s prior written consent,
settle, compromise, consent to the entry of any judgment in or otherwise seek to terminate any
threatened or pending action, claim, suit, investigation or proceeding referred to herein.

               (iv) If the indemnification provided for in this Section 3 is unavailable to or insufficient
to hold harmless an indemnified person under paragraphs 3(d)(i) or 3(d)(ii) above in respect of any
Loss (or actions or proceedings in respect thereof) referred to therein, then each indemnifying
person shall contribute to the amount paid or payable by such indemnified person as a result of
such Loss (or actions in respect thereof) in such proportion as is appropriate to reflect the
relative fault of the indemnifying person on the one hand and the indemnified person on the other
in connection with the statements or omissions or other matters which resulted in such Loss (or
actions in respect thereof), as well as any other relevant equitable considerations. The relative
fault shall be determined by reference to, among other things, in the case of an untrue statement,
whether the untrue statement relates to information supplied by the indemnified person on the one
hand or the indemnifying person on the other and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such untrue statement. The Company and the
Investors agree that it would not be just and equitable if contribution pursuant to this subsection
(d) were determined by pro rata allocation (even if the Investors were treated as one entity for
such purpose) or by any other method of allocation which does not take into account the equitable
considerations referred to above in this subsection (d). The amount paid or payable by an
indemnified person as a result of the Loss (or actions in respect thereof) referred to above in
this subsection (d) shall be deemed to include any reasonable legal fees incurred by such
indemnified person in connection with defending any such action or claim. Notwithstanding the
provisions of this subsection (d), an Investor shall not be required to contribute any amount in
excess of the amount by which the gross amount received by the Investor from the sale of the Shares
to which such Loss relates exceeds the amount of any Loss which the Investor has otherwise been
required to pay by reason of such untrue statement. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The
Investors’ obligations in this subsection to contribute are several in proportion to their sales of
Shares to which such loss relates and not joint.

          (e) The parties to this Agreement hereby acknowledge that they are sophisticated business
persons who were represented by counsel during the negotiations regarding the provisions hereof
including, without limitation, the provisions of this Section 3, and are fully informed regarding
said provisions. They further acknowledge that the provisions

7

 

of this Section 3 fairly allocate the risks in light of the ability of the parties to investigate
the Company and its business in order to assure that adequate disclosure is made in the
Registration Statement as required by the Securities Act and the Exchange Act.

     4. Termination of Conditions and Obligations. The conditions precedent imposed by Sections 4
and 6 of the Securities Purchase Agreements or this Agreement upon the transferability of the
Shares shall cease and terminate as to any particular number of the Shares when such Shares shall
have been effectively registered under the Securities Act and sold or otherwise disposed of in
accordance with the intended method of disposition set forth in the Registration Statement covering
such Shares.

     5. Information Available. So long as the Registration Statement is effective covering the
resale of Shares owned by the Investor, the Company will furnish (or, to the extent such
information is available electronically through the Company’s filings with the SEC, the Company
will make available) to the Investor, upon the reasonable request of the Investor, an adequate
number of copies of the Prospectuses (and each amendment or supplement thereto) to supply to any
other party requiring such Prospectuses either in printed or electronic form.

     6. Assignment of Registration Rights. The rights to cause the Company to register Shares
pursuant to this Agreement may be assigned (but only with the related obligations) by the Investor,
provided (i) each transfer to each transferee or designee involves (x) not less than one hundred
thousand (100,000) shares of Common Stock, (y) an affiliate of the Investor or (z) a client of the
Investor for whom or which the shares of Common Stock are beneficially held, (ii) the Company is,
within two business days after such transfer, furnished with written notice of the name and address
of such transferee or assignee, (iii) such transferee or assignee agrees in writing to assume the
obligations of this Agreement, including the obligations to furnish the Company such information
and representations regarding the transferee or assignee and the Shares to be sold by the
transferee or assignee as shall be required to effect the registration of the shares and/or sale
under Rule 144 (including the information and representations required by the Confidential Investor
Questionnaire and the Selling Stockholder Questionnaire) and (iv) such assignment shall be
effective only if immediately following such transfer the further disposition of such shares by the
transferee or assignee is restricted under the Securities Act.

     7. Notices. All notices, requests, consents and other communications hereunder shall be in
writing, shall be delivered (A) if within the United States, by first-class registered or certified
mail, or nationally recognized overnight express courier, postage prepaid, or by email or
facsimile, or (B) if from outside the United States, by International Federal Express (or
comparable service) or by email or facsimile, and shall be deemed given (i) if delivered by
first-class registered or certified mail domestic, upon the Business Day received, (ii) if
delivered by nationally recognized overnight carrier, one (1) Business Day after timely delivery to
such carrier, (iii) if delivered by International Federal Express (or comparable service), two (2)
Business Days after timely delivery to such carrier, (iv) if delivered by email or facsimile, upon
confirmation of receipt and shall be addressed as follows, or to such other address or addresses as
may have been furnished in writing by a party to another party pursuant to this paragraph:

          (a) if to the Company, to:

8

 

3D Systems Corporation

333 Three D Systems Circle

Rock Hill, SC 29730

Attention: Robert M. Grace, Jr.

Vice President, General Counsel and Secretary

Telephone: (803) 326-3989

Facsimile: (803) 324-4311

Email: GraceB@3DSystems.com

with a copy to:.

Kennedy Covington Lobdell & Hickman, L.L.P.

Hearst Tower, 47th Floor

214 N. Tryon St.

Charlotte, North Carolina 28202

Attention: Sean M. Jones

Telephone: (704) 331-7406

Facsimile: (704) 353-3106

Email: sjones@kennedycovington.com

          (b) if to the Investor, at its address on the signature page to the Securities Purchase
Agreement.

     8. Amendments; Waiver. This Agreement may not be modified or amended, and no right, term or
provision hereunder may be waived, except pursuant to an instrument in writing signed by the
Company and Investors holding a majority of the Shares (which shall be deemed to include for
purposes of this Section 8 any securities issued or issuable upon any stock split, dividend or
other distribution, recapitalization or similar event with respect to the Shares). The Company
shall provide prior notice to all Investors of any proposed amendment or waiver.

     9. Headings. The headings of the various sections of this Agreement have been inserted for
convenience of reference only and shall not be deemed to be part of this Agreement.

     10. Entire Agreement; Severability. This Agreement sets forth the entire agreement and
understanding of the parties relating to the subject matter hereof and supersedes all prior and
contemporaneous agreements, negotiations and understandings between the parties, both oral and
written relating to the subject matter hereof. If any provision contained in this Agreement is
determined to be invalid, illegal or unenforceable in any respect, the validity, legality and
enforceability of the remaining provisions contained herein shall not in any way be affected or
impaired thereby.

     11. Governing Law. This Agreement, including all matters relating to its execution, delivery
and performance, shall be governed by, and construed in accordance with, the internal laws of the
State of New York, without giving effect to the principles of conflicts of law.

     12. Counterparts. This Agreement may be executed in two or more counterparts,

9

 

each of which shall constitute an original, but all of which, when taken together, shall constitute
but one instrument, and shall become effective when one or more counterparts have been signed by
each party hereto and delivered to the other parties. The parties hereto confirm that any
facsimile or electronic copy of another party’s executed counterpart of this Agreement (or its
signature page thereof) will be deemed to be an executed original thereof.

[SIGNATURE PAGES FOLLOW]

10

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Robert M. Grace, Jr.	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Robert M. Grace, Jr.	 	 
	 	 	Title: Vice President, General Counsel and Secretary	 	 

	 	 	 	 	 	 	 	 	 
	 	 	[INVESTOR NAME]	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Its:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:
	 	 	 	 	 	 
	 

	 	Its:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 	 	Email Address:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 	 	Attn.:	 	 	 	 	 	 
	 	 	 	 	 	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 
	 	3D SYSTEMS CORPORATION

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 

	 	 	 	 	 
	 	T. Rowe Price Small-Cap Value Fund, Inc.

 	 
	 	By: /s/ Preston G. Athely	
 
	 	  

 	 
	 	      Preston G. Athely 	 
	 	Its: President 	 
	 
	 	Address: 	   T. Rowe Price Associates

  100 East Pratt Street

  Baltimore, MD 21202

 	 
	 	Facsimile No.: 410-345-6575

Email Address: Darrell_Braman@troweprice.com

Attn.: Darrell Braman

          Vice President

 	 
	 	 	 
	 	 	 
	 	 	 
	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 
	 	3D SYSTEMS CORPORATION

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	Cranshire Capital, L.P.

 	 
	 	By:  	/s/ Lawrence A. Prosser
 	 
	 	 	Its: CFO – Downsfield Capital, Inc. - 	 
	 	 	The General Partner 	 
	 
	 	 	 
	 	By:  	 	 
	 	Its: 	 
	 	 	 	 
	 
	 	 Address: 3100 Dundee Road, Suite 703

                Northbrook, IL 60062

 	 
	 	Facsimile No.: 847-562-9031

Email Address: mkopin@cranshirecapital.com

Attn.: Mitchell P. Kopin

 	 
	 	 	 
	 	 	 
	 	 	 
	 

     [SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 
	 	3D SYSTEMS CORPORATION

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	Enable Growth Partners LP

 	 
	 	By:  	/s/ Adam Epstein
 	 
	 	 	Name:  	Adam Epstein 	 
	 	 	Its: Principal 	 
	 
	 	 	 
	 	By:  	 	 
	 	Its: 	 
	 	 	 	 
	 
	 	Address: One Ferry Building, Suite 255, San Diego, CA 94111

Facsimile No.: 415-677-1580

Email Address: aepstein@enablecapital.com

Attn.: Adam Epstein

 	 
	 	 	 
	 	 	 
	 	 	 
	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 
	 	3D SYSTEMS CORPORATION

 	 
	 	By:  	 	 
	 	Name:  	 	 
	 	Title:  	 	 
	 
	 	Enable Opportunity Partners LP

 	 
	 	By:  	/s/ Adam Epstein
 	 
	 	 	Name:  	Adam Epstein 	 
	 	 	Its: Principal 	 
	 
	 	 	 
	 	By:  	 	 
	 	Its: 	 
	 	 	 	 
	 
	 	Address: One Ferry Building, Suite 255, San Diego, CA 94111

Facsimile No.: 415-677-1580

Email Address: aepstein@enablecapital.com

Attn.: Adam Epstein

 	 
	 	 	 
	 	 	 
	 	 	 
	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Pierce
	 	Diversified Strategy Masters Fund LLC, Ena 	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Adam Epstein
 

Adam Epstein
	 	 
	 

	 	Its:
	 	Principal	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Its:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Address: One Ferry Building, Suite 255, San Diego, CA 94111	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 415-677-1580

Email Address: aepstein@enablecapital.com

Attn.: Adam Epstein	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Fort Mason Master, LP	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Its:
	 	/s/ Fort Mason Capital, LLC
 

General Partner
	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Dan German	 	 
	 	 	 	 	 
	 	 	By: Dan German

Its: Managing Member	 	 
	 
	 	 	 	 	 	 
	 	 	Address: 4 Embarcadero Center	 	 
	 

	 	 	 	   Suite 2050

   San Francisco, CA 94111	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 415-288-8113

Email Address: mjensen@fortmasoncapital.com

                          klynch@fortmasoncapital.com

Attn.: Marshall Jensen and KC Lynch	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Fort Mason Partners, LP	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Its:
	 	/s/ Fort Mason Capital, LLC
 

General Partner
	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Dan German	 	 
	 	 	 	 	 
	 	 	By: Dan German

Its: Managing Member	 	 
	 
	 	 	 	 	 	 
	 	 	Address: 4 Embarcadero Center	 	 
	 

	 	 	 	   Suite 2050

   San Francisco, CA 94111	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 415-288-8113

Email Address: mjensen@fortmasoncapital.com

                          klynch@fortmasoncapital.com

Attn.: Marshall Jensen and KC Lynch	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Ottley Properties, LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Michael B. White
 

Michael B. White
	 	 
	 

	 	Its:
	 	Managing Partner	 	 
	 
	 	 	 	 	 	 
	 	 	Address: 337 Metairie Rd., Suite 202
	 	 
	 

	 	 	 	   Metairie, LA 70005	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 504-833-7911

Email Address: michael@mbwhite.net

Attn.: Michael B. White	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Zemurray Foundation	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Thomas B. Lemann
 

Thomas B. Lemann
	 	 
	 

	 	Its:
	 	Secretary	 	 
	 
	 	 	 	 	 	 
	 	 	Address: 228 St. Charles Ave. Suite 1024
	 	 
	 

	 	 	 	   New Orleans, LA 70130	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 504-522-2747

Email Address: sandyviii@villere.com

Attn.: St. Denis J. Villere III (Sandy)	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	The Society for the Relief of Destitute
Orphan Boys – AKA Waldo Burton	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Frank A. M. Williams
 

Thomas B. Lemann
	 	 
	 

	 	Its:
	 	Authorized Agent	 	 
	 
	 	 	 	 	 	 
	 	 	Address: 3320 South Carrolton Avenue
	 	 
	 

	 	 	 	   New Orleans, LA 70118	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 504-522-2747

Email Address: sandyviii@villere.com

Attn.: Sandy Villere Jr. (Sandy)	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Karnak Partners LP	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Its:
	 	/s/ Bernard Setz
 

Managing Partner
	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Its:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Address: 600 5th Ave, 25th Floor
	 	 
	 

	 	 	 	   New York, NY 10020	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: (212) 218-8280

Email Address: bselz@selzcapital.com

Attn.: Bernard Selz	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Kirsch-Cassis Profit Sharing Plan	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

	/s/ Bernard Setz
 

	 	 
	 

	 	Its:

	Trustee
 

	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Its:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Address: Selz Capital L.L.C.	 	 
	 

	 	 	 	   600 5th Ave, 25th Floor

   New York, NY 10020	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: (212) 218-8280

Email Address: bselz@selzcapital.com

Attn.: Bernard Selz	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Bernard Selz	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	/s/ Bernard Setz
 

	 	 
	 
	 	 	 	 	 	 
	 	 	Address: Selz Capital LLC	 	 
	 

	 	 	 	   600 Fifth Ave, 25th Floor

   New York, NY 10020	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: (212) 218-8280

Email Address: bselz@selzcapital.com

Attn.: Bernard Selz	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Skylands Quest LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

	/s/ Skylands Capital, LLC
 

	 	 
	 

	 	Its:

	Managing Member
 

	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Pamela A. Cavanaugh	 	 
	 	 	 	 	 
	 	 	By: Pamela A. Cavanaugh

Its: Vice President	 	 
	 
	 	 	 	 	 	 
	 	 	Address: c/o Skylands Capital, LLC	 	 
	 

	 	 	 	   1200 N. Mayfair Road, Suite 250

   Milwaukee, WI 53226	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 414-256-3396

Email Address: sp@skylandcapital.com;

                          pc@skylandcapital.com

Attn.: Steve Pulito, Pamela Cavanaugh	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be
duly executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 
	 	 	Skylands Special Investment II LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Skylands Capital, LLC	 	 
	 

	 	 	 	 	 	 
	 

	 	Its:
	 	Managing Member	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Pamela A. Cavanaugh	 	 
	 	 	 	 	 
	 	 	By: Pamela A. Cavanaugh	 	 
	 	 	Its: Vice President	 	 
	 
	 	 	 	 	 	 
	 	 	Address: c/o Skylands Capital, LLC	 	 
	 

	 	 	 	    1200 N. Mayfair Road, Suite 250	 	 
	 

	 	 	 	    Milwaukee, WI 53226	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 414-256-3396	 	 
	 	 	Email Address: sp@skylandcapital.com;	 	 
	 

	 	 	 	              pc@sp@skylandcapital.com	 	 
	 	 	Attn.: Steve Pulito, Pamela Cavanaugh	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Skylands Special Investment LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Skylands Capital, LLC	 	 
	 

	 	 	 	 	 	 
	 

	 	Its:
	 	Managing Member	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Pamela A. Cavanaugh	 	 
	 	 	 	 	 
	 	 	By: Pamela A. Cavanaugh	 	 
	 	 	Its: Vice President	 	 
	 
	 	 	 	 	 	 
	 	 	Address: c/o Skylands Capital, LLC	 	 
	 

	 	 	 	    1200 N. Mayfair Road, Suite 250	 	 
	 

	 	 	 	    Milwaukee, WI 53226	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 414-256-3396	 	 
	 	 	Email Address: sp@skylandcapital.com;	 	 
	 

	 	 	 	             pc@ skylandcapital.com	 	 
	 	 	Attn.: Steve Pulito, Pamela Cavanaugh	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Harbour Holdings Ltd.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Pamela A. Cavanaugh	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Pamela A. Cavanaugh	 	 
	 	 	Its: Vice President	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Its:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Address: c/o Skylands Capital, LLC	 	 
	 

	 	 	 	     1200 N. Mayfair Road, Suite 250	 	 
	 

	 	 	 	    Milwaukee, WI 53226	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.: 414-256-3396	 	 
	 	 	Email Address: sp@skylandcapital.com;	 	 
	 

	 	 	 	             pc@ skylandcapital.com	 	 
	 	 	Attn.: Steve Pulito, Pamela Cavanaugh	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	UBS O’Connor LLC FBO O’Connor PIPES	 	 
	 	 	Corporate Strategies Master Limited	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Nicholas Nocenho	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Nicholas Nocenho	 	 
	 	 	Its: Managing Director	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Its:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Address: c/o UBS O’Connor LLC	 	 
	 

	 	 	 	     One N. Wacker Drive, 32nd Floor	 	 
	 

	 	 	 	     Chicago, IL 60606	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.:312-525-6271	 	 
	 	 	Email Address: jeff.richmond@ubs.com	 	 
	 	 	Attn.: Jeff Richmond	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Atlas Allocation Fund, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Atlas Capital Management, L.P.	 	 
	 

	 	 	 	 	 	 
	 

	 	Its:
	 	General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ RHA, Inc.	 	 
	 

	 	 	 	 	 	 
	 

	 	Its:
	 	General Partner	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Robert H. Alpert	 	 
	 	 	 	 	 
	 	 	By: Robert H. Alpert	 	 
	 	 	Its: President	 	 
	 
	 	 	 	 	 	 
	 	 	Address: 100 Crescent Court, Suite 800	 	 
	 

	 	 	 	     Dallas, TX 75201	 	 
	 
	 	 	 	 	 	 
	 	 	Facsimile No.:214-999-6095	 	 
	 	 	Email Address: caryn@atlascap.net	 	 
	 	 	Attn.: Caryn Peeples	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:	 	 	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Capital Ventures International	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Heights Capital Management, Inc.	 	 
	 

	 	 	 	 	 	 
	 

	 	Its:
	 	Authorized agent	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Martin Kobinger	 	 
	 	 	 	 	 
	 	 	By: Martin Kobinger	 	 
	 	 	Its: Investment Manager	 	 
	 
	 	 	 	 	 	 
	 	 	Address: c/o Heights Capital Management	 	 
	 

	 	 	 	     101 California Street, Suite 3250	 	 
	 

	 	 	 	     San Francisco, CA 94111	 	 
	 
	 	 	Facsimile No.: 415-403-6265	 	 
	 	 	Email Address: samwiner@sig.com or	 	 
	 

	 	 	 	              martinkobinger@sig.com	 	 
	 	 	Attn.: Sam Winer or Martin Kobinger	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Goldring Family Foundation, I	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Alan Franco	 	 
	 	 	 	 	 	 	 
	 	 	Name: Alan Franco	 	 
	 	 	Its: Trustee	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 

	 	Its:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	809 Jefferson Hwy	 	 
	 

	 	 	 	 	 	New Orleans, LA 70121	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 504-849-6515	 	 
	 	 	Email Address: alanfranco@rndc-usa.com	 	 
	 	 	Attn.: Alan Franco	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Woldenburg Foundation	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Alan Franco	 	 
	 	 	 	 	 	 	 
	 	 	Name: Alan Franco	 	 
	 	 	Its: Trustee	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	 
	 	 	Its:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	809 Jefferson Hwy	 	 
	 

	 	 	 	 	 	New Orleans, LA 70121	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 504-849-6515	 	 
	 	 	Email Address: alanfranco@rndc-usa.com	 	 
	 	 	Attn.: Alan Franco	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Diane Franco	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Diane Franco	 	 
	 	 	 	 	 	 	 
	 	 	Name: Diane Franco	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	 
	 	 	Its:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	809 Jefferson Hwy	 	 
	 

	 	 	 	 	 	New Orleans, LA 70121	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 504-849-6515	 	 
	 	 	Email Address: alanfranco@rndc-usa.com	 	 
	 	 	Attn.: Alan Franco	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Alan Franco	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Alan Franco	 	 
	 	 	 	 	 	 	 
	 	 	Name: Alan Franco	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 

	 	Its:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	809 Jefferson Hwy	 	 
	 

	 	 	 	 	 	New Orleans, LA 70121	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 504-849-6515	 	 
	 	 	Email Address: alanfranco@rndc-usa.com	 	 
	 	 	Attn.: Alan Franco	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Straus Partners LP	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By: 	 /s/ Craig Connors	 	 
	 	 	 	 	 	 
	 	 	Its: Chief Financial Officer	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	 
	 	 	Its:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	320 Park Avenue	 	 
	 

	 	 	 	 	 	New York, NY 10022	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 212-415-7256	 	 
	 	 	Email Address: cconnors@strauspartners.com	 	 
	 	 	Attn.: Craig Connors	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Straus-GEPT Partners LP	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By: 	/s/ Craig Connors	 	 
	 	 	 	 	 	 
	 	 	Its: Chief Financial Officer	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	 
	 	 	Its:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	320 Park Avenue	 	 
	 

	 	 	 	 	 	New York, NY 10022	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 212-415-7256	 	 
	 	 	Email Address: cconnors@strauspartners.com	 	 
	 	 	Attn.: Craig Connors	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Telemark Fund, LP	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Robert M. Grace, Jr.	 	 
	 	 	 	 	 	 	 
	 	 	Name: Brian C. Miley	 	 
	 	 	Its: Chief Financial Officer	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	 
	 	 	Its:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	Telemark Asset Management, LLC	 	 
	 

	 	 	 	 	 	One International Place	 	 
	 

	 	 	 	 	 	Suite 2401	 	 
	 

	 	 	 	 	 	Boston, MA 02110	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 617-526-8909	 	 
	 	 	Email Address: bmiley@telemarkasset.com	 	 
	 	 	Attn.: Brian Miley	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	SRB Greenway Offshore Operating Fund, L.P.	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	/s/ SRB Management, L.P.	 	 
	 	 	 	 	 	 
	 	 	Its: General Partner	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By: 	/s/ BC Advisors, L.L.C.	 	 
	 	 	 	 	 	 
	 	 	Its: General Partner	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	/s/ Steven R. Becker	 	 
	 	 	 	 	 
	 	 	By: Steven R. Becker	 	 
	 	 	Its: Member	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	SRB Greenway Offshore Operating	 	 
	 

	 	 	 	 	 	Fund, L.P.	 	 
	 

	 	 	 	 	 	300 Crescent Court Suite 1111	 	 
	 

	 	 	 	 	 	Dallas, TX 75201	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.:241-756-6079	 	 
	 	 	Email Address: george@greenwaycapital.net	 	 
	 	 	Attn.: George Lee	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	SRB Greenway Capital (QP), L.P.	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By: 	/s/ SRB Management, L.P.	 	 
	 	 	 	 	 	 
	 	 	Its: General Partner	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By: 	/s/ BC Advisors, L.L.C.	 	 
	 	 	 	 	 	 
	 	 	Its: General Partner	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	/s/ Steven R. Becker	 	 
	 	 	 	 	 
	 	 	By: Steven R. Becker	 	 
	 	 	Its: Member	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	SRB Greenway Capital (QP), L.P.	 	 
	 

	 	 	 	 	 	300 Crescent Court Suite 1111	 	 
	 

	 	 	 	 	 	Dallas, TX 75201	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.:241-756-6079	 	 
	 	 	Email Address: george@greenwaycapital.net	 	 
	 	 	Attn.: George Lee	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

 

 

     IN WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly
executed as of the date first written above.

	 	 	 	 	 	 	 	 	 
	 	 	3D SYSTEMS CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Name:	 	 
	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	/s/ SRB Management, L.P.	 	 
	 	 	 	 	 	 
	 	 	Its: General Partner	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	/s/ BC Advisors, L.L.C.	 	 
	 	 	 	 	 	 
	 	 	Its: General Partner	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	/s/ Steven R. Becker	 	 
	 	 	 	 	 
	 	 	By: Steven R. Becker	 	 
	 	 	Its: Member	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:	 	SRB Greenway Capital, L.P.	 	 
	 

	 	 	 	 	 	300 Crescent Court Suite 1111	 	 
	 

	 	 	 	 	 	Dallas, TX 75201	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Facsimile No.: 241-756-6079	 	 
	 	 	Email Address: george@greenwaycapital.net	 	 
	 	 	Attn.: George Lee	 	 

[SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]EX-10.1 LICENSE AGREEMENT

 

Exhibit 10.1

LICENSE AGREEMENT

FOR INDEX-RELATED DERIVATIVE PRODUCTS

BETWEEN FRANK RUSSELL COMPANY

AND INTERCONTINENTAL-EXCHANGE, INC.

[Certain information in this agreement has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect to the
omitted portions.]

     This License Agreement (the “Agreement”), is entered into as of
June 15, 2007 (the “Effective Date”), by and between the Frank Russell Company (“RUSSELL”) and
INTERCONTINENTAL-EXCHANGE, INC. (“Licensee”).

     WHEREAS, RUSSELL is an international financial services firm and the owner of intellectual
property and other rights in and associated with a series and family of securities indexes (each,
a “Russell US Index” and collectively the “Russell Indexes”), including without limitation
“Russell 1000”, “Russell 2000” and “Russell 3000”. RUSSELL determines and weights the components
of the Russell US Indexes and calculates, maintains and disseminates the Russell US Indexes on a
time-sensitive basis.

     WHEREAS, the Russell US Indexes are associated with various registered and unregistered trade
names, trademarks and service marks owned by RUSSELL (the “Russell Mark(s)”). The use of the
Russell Marks implies, and/or is likely to cause third parties to infer, an association between
the user of the Russell Marks and RUSSELL and the substantial reputation and good will maintained
by RUSSELL and its affiliates.

     WHEREAS, Licensee operates Board of Trade of the City of New York, Inc. (“NYBOT”), a regulated
commodities exchange, and operates or intends to operate the facilities specified in Exhibit A (the
“Exhibit A Affiliates”) (NYBOT and the Exhibit A Affiliates are each referred to herein as the
“Licensed Exchange”). Licensee desires to design, create, issue, list, trade, and/or facilitate
the trading of, one or more financial products (“Derivative Products”) derived in whole or in part
from, or otherwise associated with, either (i) one or more Russell US Indexes and/or the Russell
Marks or (ii) interests in funds or other securities issued by others that are derived in whole or
in part from, or are otherwise associated with, one or more Russell US Indexes and/or the Russell
Marks. Licensee further desires to engage in marketing and promotional activities related to
certain Derivative Products and the listing and/or trading thereof on or through the Licensed
Exchange, and in that connection, to use the associated Russell Marks. Licensee desires, and
acknowledges that it requires, a license and other permissions from RUSSELL to do so.

     WHEREAS, RUSSELL is willing on an exclusive basis as described in Section 4 to license and
otherwise permit Licensee on the terms of this Agreement to engage in certain activities involving
certain Derivative Products as expressly provided herein.

     NOW THEREFORE, in consideration thereof and the following covenants and conditions, and for
good and valuable consideration, the receipt of which is hereby acknowledged, the parties,
intending to be legally bound, hereby agree as follows:

     1. License Grant. Subject to the terms of this Agreement including the termination or
expiration of the waiting period applicable to this Agreement under the Hart-Scott Rodino Antitrust
Improvements Act of 1976, as amended (the “HSR Act”), RUSSELL hereby grants Licensee an exclusive
as described in Section 4.2, transferable and sub-licensable license, under and to the Russell US
Indexes and the Russell Marks, for use within the territory (the “Territory”) and subject to the
territorial

- 1 -

 

restrictions, if any, described in Exhibit A hereto, and during the term stated in Section 3
(the “Term”) or an applicable Closing Period (as defined in Section 5):

          (a) to design, create, and/or issue (collectively, to “Issue”, “Issued” or to effect the
“Issuance” of) the particular Derivative Products listed in Exhibit B (the “Licensed Derivative
Products”);

          (b) to list or otherwise facilitate the trading by others of the Licensed Derivative
Products (to “List”, “Listed” or “Listing”) on or through the Licensed Exchange, (including
the Exhibit A Affiliates) if legally qualified to list and trade the Licensed Derivative
Products;

          (c) to permit and/or authorize distributors, underwriters, syndicators, market makers,
brokers, dealers, and futures commission merchants that hold current and active rights to engage in
and to effect trades of financial products generally on or through the Licensed Exchange (the
“Authorized Traders”), to Issue and to List one or more of the Licensed Derivative Products on or
through the Licensed Exchange (including the Exhibit A Affiliates);

          (d) to engage in marketing and other promotional activities with respect to the activities
stated in clauses (a), (b) and (c) above using advertising, sales promotion, training, and/or
demonstration methods and materials (collectively “Marketing Methods and Materials”), subject to
the conditions stated herein;

          (e) to indicate that RUSSELL is the source of the Russell US Index on which such Licensed
Derivative Products are based (the “Associated Russell US Index”) as may be required by
applicable laws, rules, regulations, court orders or this Agreement; and

          (f) to disseminate the index values of the Associated Russell US Indexes, as provided by
RUSSELL, to securities information processors, communications vendors, and news services for
informational purposes in connection with the Issuance and the Listing of the Licensed Derivative
Products on or through the Licensed Exchange.

     2. Clearing.

          If the Agreement fails to be exclusive with respect to any Index as described in Section 4.4
or 4.5, RUSSELL may request that Licensee cause the Licensed Exchange, and its clearing
organization, to enter into an agreement with all other U.S. commodity exchanges on which the same
Licensed Derivative Products are traded, and their respective clearing organizations, that will
provide traders the ability to initiate a contract in a common Licensed Derivative Product on one
exchange and offset or closeout such contract by a transaction executed on another exchange,
provided, however, that each other exchange on which the common Licensed Derivative Product is
listed for trading, and its respective clearing organization, has executed a definitive written
agreement providing for the ability to so initiate and close-out positions in common Licensed
Derivative Products and provided further, however, that RUSSELL may terminate this Agreement with
respect to such common Licensed Derivative Product, but shall not be entitled to any damages for
breach of contract or otherwise, in the event that the Licensed Exchange and its clearing
organization fail to execute such definitive written agreement.

     3. Term.

          Licensee’s rights under this Agreement shall commence on the Effective Date and shall
continue, unless terminated as provided herein, through July 1, 2014 (“the Initial Term”).
Following the expiration of the Initial Term, Licensee’s rights under this Agreement, including
exclusivity, shall be automatically renewed for successive one (1) year periods (each a “Renewal
Term”) unless either party

- 2 -

 

provides the other party with at least ninety (90) days prior written notice before the end of
the Initial Term or any Renewal Term of its intent to not renew the Agreement. The Initial Term
and the Renewal Terms (if any) shall together constitute the “Term” under this Agreement.

     4. Exclusivity.

          4.1 Licensee understands that RUSSELL has licensed other exchanges (“other licensees”), with
respect to one or more of the Licensed Derivative Products, to engage in one or more of the
activities and rights licensed under Section 1 of this Agreement (the “Existing Licenses”).

          (a) RUSSELL represents and warrants that the Existing Licenses will expire on or about
November 1, 2007, and January 29, 2008 subject, however to the other licensee’s limited rights and
obligations during a closing period following such expiration, with the closing period being
similar to the Closing Period described in Section 5 below.

          (b) RUSSELL represents and agrees that it shall not renew or extend the Existing Licenses
beyond their expiration date of on or about November 1, 2007 and January 29, 2008.

          (c) RUSSELL acknowledges and agrees that Licensee’s rights under this Agreement commencing on
the Effective Date shall be exclusive, with the exception of any of Licensee’s rights that overlap
the Existing Licenses, which rights shall be non-exclusive until expiration of the Existing
Licenses and any applicable closing period, and then Licensee’s rights shall be exclusive
thereafter for the remainder of the Term under this Agreement, subject to the Exclusivity Term set
forth below.

          (d) RUSSELL represents and agrees that promptly following the Effective Date of this
Agreement, it shall send a notice of termination to the other licensee advising that the Existing
Licenses shall expire on November 1, 2007 and January 29, 2008, respectively and will not be
renewed or extended. If any other licensees continue to engage in the Issuance or Listing of
Licensed Derivative Products after expiration of the rights granted in their Existing Licenses,
RUSSELL agrees to undertake an action or actions against such other licensees to protect the
Licensees rights under this Agreement. RUSSELL shall pay the expenses incurred in connection with
such action or actions.

          4.2 RUSSELL represents and agrees that it will not, with effect at any time during the
Exclusivity Term (as defined below) applicable to a particular Licensed Derivative Product, grant a
license to any third party (other than under the Existing Licenses as described above) to Issue or
to List such Licensed Derivative Product in the Territory.

          4.3 The “Exclusivity Term” with respect to a Licensed Derivative Product shall mean the
shortest of the following periods, as applicable to such Licensed Derivative Product in a given
country:

          (a) the period from the Effective Date until the occurrence of a US or Global Triggering Event
(as defined below) with respect to the Associated Russell US Index for such Licensed Derivative
Product;

          (b) the period from the Effective Date until a court of competent country determines in a
final ruling that the exclusivity provisions of this Section 4 are unenforceable in the Territory
as applied to such Licensed Derivative Product or the Associated Russell US Index for such Licensed
Derivative Product; and

          (c) the period from the Effective Date until the end of the Term.

- 3 -

 

          4.4

          (a) U.S. Triggering Event. If, during any two consecutive calendar quarters,
beginning on or after three years from the Effective Date, Licensee fails to maintain an average
trading volume of at least [**] contracts per day (“Minimum U.S. Average Daily Trading Volume”) on
any of the Exhibit A Affiliates, in the aggregate, for a particular Russell US Index (in the
aggregate for all contracts for all Licensed Derivative Products that are based on such Russell US
Index), RUSSELL may, in its sole discretion, elect to convert Licensee’s exclusivity rights in the
United States with respect to all Licensed Derivative Products based on such Russell US Index to
non-exclusive rights upon giving Licensee at least thirty (30) days prior written notice of such
election. Such conversion at the end of such notice period shall be a “US Triggering Event” with
respect to that Russell US Index. For purposes of this Agreement, the term “contract” shall be
used to identify a financial instrument comprising a matched long and short position.

          (b) Global Triggering Event. If, during any two consecutive calendar quarters,
beginning on or after one year following Licensee’s initial Issuing or Listing in any non-US
country according to Section 4.6 below, Licensee and/or any licensed third party, in the aggregate,
fail to maintain an average trading volume of at least [**] contracts per day in such non-US
country (“Minimum Global Average Daily Trading Volume”) for a particular Russell US Index, RUSSELL
may, in its sole discretion, elect to convert Licensee’s non-U.S. exclusivity rights in that
country with respect to all Licensed Derivative Products based on such Russell US Index to
non-exclusive rights upon giving Licensee at least thirty (30) days prior written notice of such
election. Such conversion at the end of such notice period shall be a “Global Triggering Event”
with respect to that Russell US Index traded in that particular country, but shall in no way affect
Licensee’s rights with respect to other Russell US Indexes or other countries.

          4.5 During any period in which Licensee is not actively Listing any Licensed Derivative
Product based on a particular Russell US Index, RUSSELL may, from time to time and by written
notice to Licensee (a “Forcing Option Notice”), require Licensee to elect whether or not Licensee
will take prompt action to Issue and List one or more Licensed Derivative Products based on such
Russell US Index. Upon receipt of a Forcing Option Notice, Licensee shall either:

          (a) send a written response to RUSSELL within thirty (30) days of its receipt of such Forcing
Option Notice that Licensee does not intend to Issue and List a Derivative Product based on the
applicable Russell US Index (which response shall be a “US Triggering Event” with respect to the
applicable Russell US Index if the Licensee does not intend to Issue or List in the US or a Global
Triggering Event if Licensee does not intend to Issue or List in the particular country which is
the subject of the Forcing Option Notice); or

          (b) begin, within no more than ninety (90) days of its receipt of such Forcing Option Notice,
to Issue and List on a sustained basis at least one Licensed Derivative Product based on the
applicable Russell US Index. If Licensee fails to comply with this clause (b), the expiration of
such 90-day period shall at RUSSELL’s option (exercisable upon written notice to Licensee within 30
days thereafter) be a “US Triggering Event” with respect to that Russell US Index if the failure
relates to the US, and a “Global Triggering Event” if the failure relates to a non-US country.

 

			
	**	 	Certain information on this page has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

- 4 -

 

          4.6

          (a) During any period in which Licensee is not licensed for trading in a country and RUSSELL
desires that Licensee provide access to the Licensed Derivative Products in that country, RUSSELL
and Licensee will agree to a reasonable time period but in no event greater than 180 days to allow
Licensee to either obtain the necessary regulatory approvals to provide the Licensed Derivative
Products in that country, or to enter into a relationship with a third party already having the
necessary regulatory approvals to provide the Licensed Derivative Products in that country. In
connection with Licensee entering into a relationship with a third party to provide the Licensed
Derivative Products, Russell shall have the sublicense approval rights specified in Section 18 of
this Agreement; provided, however, that if Russell does not consent to a sublicense to a bona fide
third party with whom Licensee desires to establish a relationship, Russell shall have no further
right to license to any other third party as provided hereafter in this paragraph. If after such
time period, Licensee has not obtained the necessary regulatory approvals or entered into a
relationship with a third party to provide the Licensed Derivative Products, and RUSSELL in its
sole discretion has not extended the time period for Licensee to obtain approvals, then RUSSELL
shall have the limited right to license the Russell US Indexes and the Russell Marks to a third
party in that specific country to Issue or List the Licensed Derivative Products and will take
appropriate measures to ensure that the license to the third party does not in any way compete
with, interfere with or impede Licensee’s rights under this Agreement, provided, however, that any
such license is limited to the Issuing or Listing of Licensed Derivative Products for trading in
said country or countries and Russell and Licensee shall make good faith efforts to enforce such
limitation. Licensee will be permitted to Issue and List the Licensed Derivative Products in the
territory in question even after RUSSELL provides the third party with the limited license.

          (b) During any period in which Licensee is not licensed for trading in a country and RUSSELL
is approached by a third party desiring to Issue and List the Licensed Derivative Products and
RUSSELL desires that such third party be able to Issue and List in that country and such third
party [**] contracts per day from such country, RUSSELL shall inform Licensee of such third party,
and Licensee shall have the option to:

(i) agree to a minimum average trading volume to at least [**] contracts per day in
said country commensurate with the obligations outlined in Section 4.4(b); or

(ii) enter into a relationship with such third party to provide an average trading
volume of at least [**] contracts per day in said country commensurate with the
obligations outlined in Section 4.4(b),

in each case in order to maintain exclusivity in such country.

           In the event that Licensee fails to fulfill either of options (i) or (ii) within a reasonable
time period as agreed to by RUSSELL and Licensee, but in no event greater than 180 days, and
RUSSELL in its sole discretion has not extended the time period, RUSSELL shall have the limited
right to license the Russell US Indexes and the Russell Marks to a third party in that specific
country to Issue or List the Licensed Derivative Products and will take appropriate measures to
ensure that the license to the third party does not in any way compete with, interfere with or
impede Licensee’s rights under this Agreement, provided, however, that any such license is limited
to the Issuing or Listing of Licensed

 

			
	**	 	Certain information on this page has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

- 5 -

 

Derivative Products for trading in said country or countries and Russell and Licensee shall make
good faith efforts to enforce such limitation. Licensee will be permitted to Issue and List the
Licensed Derivative Products in the territory in question even after RUSSELL provides the third
party with the limited license. For the avoidance of doubt, RUSSELL’s notification to Licensee
under 4.6(b) herein shall be considered as RUSSELL’s consent for Licensee to sublicense or delegate
this Agreement and any rights or obligations hereunder to such third party in said country.

     5. Closing Period Rights and Obligations.

               If and to the extent that any contracts for Licensed Derivative Products have open interests
at the end of the Term, Licensee shall, at its option: (i) continue to facilitate the trading of
such contracts through their expiration, provided such expiration shall not occur later than one
(1) year following the end of the Term (such trading through expiration is called the “Closing
Period” herein), (ii) permit another exchange to trade those contracts during the Closing Period,
or (iii) arrange for the open interest to be closed out during the Closing Period via the
clearing-corporation where the open interest is held.

     6. Calculation and Continuity of the Associated Russell US Indexes.

          6.1 At no cost to Licensee other than the fees described in Exhibit D (the “Fees”), RUSSELL
or its agent shall compute and make available for transmission to and reception by vendors the
index value of each Associated Russell US Index at least once every fifteen seconds during normal
trading hours of the Licensed Exchange. RUSSELL reserves the right to require recipients of
Russell US Index values to be validated as current subscribers to Russell US Index services.

          6.2 Each day that the Licensed Exchange is open for business, RUSSELL shall, upon receipt of
a final closing value of each Associated Russell US Index, designate an official closing index
value for that Associated Russell US Index for purposes of this Agreement. RUSSELL shall exert
commercially reasonable efforts to provide such official closing values to the Licensee no later
than 6:00 p.m. Eastern Time on each such day.

          6.3 If RUSSELL becomes aware of an error causing a difference of .01 index points or more in
the official closing value of any Associated Russell US Index then RUSSELL shall, at its own
expense, use commercially reasonable efforts to correct such error in a timely fashion. RUSSELL
shall disseminate the revised closing value through its normal channels of dissemination.

          6.4 RUSSELL shall use commercially reasonable efforts to preserve the continuity and
consistency of each Associated Russell US Index as a measure of that segment of the market such
Associated Russell US Index was designed to reflect, although RUSSELL is free to select and alter
the components and methods of calculation of each Associated Russell US Index without consent of
Licensee.

          6.5 RUSSELL shall institute processes reasonably designed to give Licensee prior notice of
any material alteration to and of the Associated Russell US Indexes during the Term or the
Closing Period, if any.

          6.6 If RUSSELL, during the Term or any Closing Period, ceases to calculate or disseminate
index values for any Associated Russell US Index, RUSSELL shall, on a confidential basis, provide
Licensee with the then applicable method of calculation of the discontinued Associated Russell US
Index along with any reasonably needed past and future information.

- 6 -

 

     7. Disclaimer of Warranties. While RUSSELL will use commercially reasonable efforts based on
sources it deems adequate in calculating the Associated Russell US Indexes in accordance with its
then applicable method for calculation of such Associated Russell US Index, RUSSELL DOES NOT
WARRANT THE ACCURACY OR COMPLETENESS OF ANY RUSSELL US INDEX OR OF THE DATA USED TO CALCULATE ANY
RUSSELL US INDEX OR DETERMINE ITS COMPONENTS, OR THE UNINTERRUPTED OR UNDELAYED CALCULATION OR
DISSEMINATION OF ANY RUSSELL US INDEX. RUSSELL PROVIDES THE RUSSELL US INDEXES “AS-IS”
AND DOES NOT REPRESENT OR WARRANT THAT THE RUSSELL US INDEXES OR THE MEANS BY WHICH RUSSELL
CALCULATES THEM IS FREE OF DEFECTS. RUSSELL DOES NOT REPRESENT OR WARRANT THE TIMELINESS,
SEQUENCE, ACCURACY OR COMPLETENESS OF THE RUSSELL US INDEXES, OR THAT THE RUSSELL US INDEXES
ACCURATELY REFLECT PAST, PRESENT, OR FUTURE MARKET PERFORMANCE OR WILL MEET LICENSEE’S
REQUIREMENTS. RUSSELL DISCLAIMS ALL INDEMNITIES (EXCEPT AS OTHERWISE PROVIDED IN THIS
AGREEMENT)AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING BUT NOT LIMITED TO, ANY IMPLIED
WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR USE OR PURPOSE, ANY IMPLIED WARRANTY
ARISING FROM TRADE USAGE, COURSE OF DEALING, OR COURSE OF PERFORMANCE, AND ANY OTHER WARRANTY OR
OBLIGATION ON THE PART OF RUSSELL

     8. Promotion Efforts; Marketing Methods and Materials.

          8.1 Licensee shall throughout the Term devote continuing commercially reasonable efforts
to the development and promotion of the Licensed Derivative Products, including without
limitation through the specific activities and efforts described in Exhibit C hereto. To that end,
Licensee is free to determine, in its sole discretion, the timing and the extent to which, if at
all, the specific activities and efforts described in Exhibit C hereto will be carried out.

          8.2 All Marketing Methods and Materials which use any of the Russell Marks shall expressly
state that RUSSELL is the owner of the Russell Marks and shall include the appropriate trademark
symbol (either “SM” or “®”), as designated by RUSSELL from time to
time, and shall otherwise conform to RUSSELL’s trademark usage and notification policies as
communicated to Licensee. Such statement shall substantially take the following form, unless
RUSSELL otherwise directs:

“Russell [2000®] is a trademark and service mark of the Russell Investment Group, used
under license.”

          8.3 If Licensee or any Authorized Trader uses any material for which RUSSELL owns the
copyright, Licensee shall devote commercially reasonable efforts to assure that all copies
thereof include appropriate copyright notices in a form designated by RUSSELL.

          8.4 In any prospectus, offering memorandum, contract, or writing delivered to a third party
in connection with the Issuance or proposed Issuance of any Licensed Derivative Product, Licensee
shall devote commercially reasonable efforts to insure that substantially the following language
shall prominently appear:

“NEITHER FRANK RUSSELL COMPANY‘S PUBLICATION OF THE RUSSELL US
INDEXES NOR ITS LICENSING OF ITS TRADEMARKS FOR USE IN CONNECTION WITH SECURITIES OR OTHER
FINANCIAL PRODUCTS DERIVED FROM A RUSSELL US INDEX IN ANY WAY SUGGESTS OR IMPLIES A
REPRESENTATION OR OPINION BY FRANK RUSSELL COMPANY, INTERCONTINENTALEXCHANGE, INC. OR ANY OF
THEIR RESPECTIVE SUBSIDIARIES AS TO THE ATTRACTIVENESS OF INVESTMENT IN ANY SECURITIES OR
OTHER FINANCIAL PRODUCTS BASED UPON OR DERIVED FROM ANY RUSSELL US INDEX. FRANK RUSSELL
COMPANY, OR ANY OF ITS SUBSIDIARIES ARE NOT THE ISSUER OF ANY SUCH SECURITIES OR OTHER
FINANCIAL PRODUCTS AND MAKE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS
FOR ANY PARTICULAR PURPOSE WITH RESPECT TO ANY RUSSELL US INDEX OR ANY DATA INCLUDED OR
REFLECTED THEREIN, NOR AS TO RESULTS TO BE OBTAINED BY

- 7 -

 

ANY PERSON OR ANY ENTITY FROM THE USE OF THE RUSSELL US INDEX OR ANY DATA INCLUDED OR
REFLECTED THEREIN.”

          8.5 Solely in connection with the preservation and policing of rights in and to the
Russell Marks, RUSSELL shall have the right to review and approve prior to their use or release,
all Marketing Methods and Materials proposed or desired to be used by the Licensee or any
Authorized Trader; provided, however, that Licensee may use or release such
Marketing Methods and Materials, or permit an Authorized Trader to do so, without RUSSELL’s
approval if RUSSELL has not objected to the contents thereof within five business days of RUSSELL’s
receipt of such Marketing Methods and Materials. Licensee need not resupply any Marketing Methods
and Materials to RUSSELL as long as the same contain all required notices and disclaimer language
in unchanged and unobscured form and are substantially like the Marketing Methods and Materials
previously approved by RUSSELL to the extent they describe or refer to RUSSELL or any Russell US
Indexes or use any Russell Marks. RUSSELL shall not unreasonably withhold approval for Marketing
Methods and Materials.

          8.6 In the event that Licensee becomes aware of any particular potential, threatened, or
actual infringement or misappropriation of rights in, or unauthorized use of, any of the Russell
US Indexes or any of the Russell Marks by a third party (“Unlicensed Use”), of the Associated
Russell US Index or Russell Marks on which a Licensed Derivative Product is based that has, or can
reasonably be expected to have, a material adverse impact upon the benefits derived by the
Licensee hereunder, and RUSSELL does not undertake an action or settlement with respect to such
Unlicensed Use within thirty (30) calendar days of becoming so aware, whether by Licensee’s notice
to RUSSELL or otherwise, the Licensee shall have the right to bring an action or actions, at
Licensee’s sole discretion, against the third party to protect the benefits derived by the
Licensee hereunder. RUSSELL agrees to be designated as plaintiff, co-plaintiff or any other
suitable party designation in any action or actions, as determined appropriate in Licensee’s sole
discretion, and RUSSELL also shall as reasonably requested by Licensee from time to time and at
Licensee’s expense, cooperate with Licensee with respect to any action taken by Licensee against a
third party as described in this Section. All of all expenses incurred by Licensee on account of
any such action or actions brought against a third party, including but not limited to legal fees
and costs, shall be setoff against any royalties payable to RUSSELL pursuant to Exhibit D of this
Agreement. Any damages or fees recovered as a result of any action or actions brought against any
third parties, whether by RUSSELL or Licensee, shall be allocated first to reimburse both parties
for any expenses incurred in bringing such action or actions, including to reimburse all
outstanding royalties payable to RUSSELL that have been setoff, and with any remaining recovery to
be shared equally between the parties.

          8.7 Licensee shall as requested by RUSSELL from time to time and at RUSSELL’s expense,
cooperate with RUSSELL in the maintenance, registration, and policing of RUSSELL’s rights in the
Russell US Indexes and the Russell Marks.

          9. Fees and Audit Rights.

          9.1 Licensee shall, on a quarterly basis, provide written reports to RUSSELL itemizing the
contracts traded for each Licensed Derivative Product, and stating the average trading volume
achieved by the Licensee during such quarter for each Russell US Index. Licensee shall pay RUSSELL
the Fees specified in Exhibit D hereto. Any amount not paid within 30 days after its due date is
subject to interest at the rate of 1% per month (or, if less, the highest rate permitted by law)
until paid, plus costs of collection, including reasonable outside attorneys’ fees. Licensee shall
also assume full and complete responsibility for the payment of any taxes, charges or assessments
imposed on Licensee, by any foreign or domestic national, state, provincial, local or other
government bodies, or subdivisions thereof, and any penalties or interest (other than personal
property or income taxes imposed on RUSSELL) relating to this Agreement. In addition, if Licensee
is required by applicable law to deduct or withhold any such tax, charge or

- 8 -

 

assessment from the amounts due RUSSELL, then such amounts due shall be increased so that the
net amount actually received by RUSSELL after the deduction or withholding of any such tax, charge
or assessment, will equal one hundred percent (100%) of the charges specified herein.

          9.2 RUSSELL shall have the right, upon reasonable notice to Licensee, not more than once per
calendar year, to audit on a confidential basis, any relevant books and records of Licensee, any
Exhibit A Affiliate, or any Authorized Trader (to the extent Licensee maintains such information
and is not prohibited from disclosing such information to Russell), to determine whether Licensee
has achieved the Minimum U.S. Average Daily Trading Volume and the Minimum Global Average Trading
Volume, and to ensure that the type and amount of Fees calculated or stated to be payable to
RUSSELL are complete and accurate. Such an audit shall take place during normal business hours. If
Licensee has underreported the Fees due to RUSSELL under this Agreement by more than 5%, Licensee
shall bear the reasonable costs of such audit.

     10. Certain Limitations; Reservation of Rights and Properties.

          10.1 This Agreement affects the grant of a license to Licensee and not the sale of any rights
in the Russell US Indexes or the Russell Marks. This license does not apply to any Derivative
Products other than the Licensed Derivative Products. No implied licenses are intended hereunder
and none shall be inferred. All rights not expressly granted herein are reserved by RUSSELL.

          10.2 Licensee agrees that the Russell US Indexes are products of the selection, coordination,
arrangement, and editing of RUSSELL or its affiliates or contractors and that such efforts involve
the considerable expenditure by RUSSELL of time, effort, and judgment. As between the parties,
Licensee recognizes that RUSSELL is the rightful licensor of the Russell US Indexes and Russell
Marks. No license is granted to Licensee to calculate the Russell US Indexes.

          10.3 Each of RUSSELL and Licensee retains the right to require that a Licensed Derivative
Product be delisted if continued listing of it on the Licensed Exchange would violate the rules of
Licensee, the Commodity Futures Trading Commission (“CFTC”), the Securities and Exchange Commission
(the “SEC”) or any other applicable governmental standards in the Territory.

          10.4 RUSSELL and Licensee shall jointly select the ticker symbol for each of the
Licensed Derivative Products that is currently listed or that will be traded on more than one
exchange. Licensee may, with the prior consent of RUSSELL, which consent will not be
unreasonably withheld or delayed, choose the ticker symbol for other Licensed Derivative
Products that are not currently listed and that will be exclusively traded on the Licensed
Exchange.

          10.5 RUSSELL acknowledges that Licensee is and shall be the owner of the order, quotation,
trade, position, and other data and contents of all data bases resulting from Licensee’s systems,
and all information extracted or derived therefrom. RUSSELL shall be entitled to access and use
such data for its own internal use only subject to applicable provisions of the Commodity Exchange
Act and the Rules of the Licensee and applicable Exhibit A Affiliate but shall not redistribute the
same without the written consent of Licensee. No express or implied licenses are intended to be
granted hereunder to RUSSELL and none shall be inferred. All rights herein are reserved by
Licensee.

          10.6 The parties agree to work in good faith to launch the global index products as described
in Exhibit E attached hereto and to enter into a definitive agreement with respect to the launch of
the global index products described in Exhibit E within one month from the Effective Date.

- 9 -

 

     11. Indemnification.

          11.1 RUSSELL will defend, indemnify, and hold harmless Licensee, the Licensed Exchange
(including the Exhibit A Affiliates), and its and their respective officers, directors,
employees, and agents against any and all claims, demands, actions, suits, or proceedings
(including the reasonable costs of defense inclusive of attorneys’ fees) to the extent arising
from (i) any third party claim asserting that any Russell US Index or Russell Mark when properly
used by Licensee hereunder infringes the patent, copyright, trade secret, trademark, service
mark, or other proprietary right (“Intellectual Property”) of any third party, and (ii) the gross
negligence or willful misconduct of RUSSELL or its officers, directors, employees or agents.

          11.2 Licensee represents and warrants that the Licensed Exchange has or will have at the
time of listing, all necessary rights to Issue and List the Licensed Derivative Products and to
promote the same, other than the rights obtained by Licensee from RUSSELL under this Agreement.
Licensee represents and warrants that each Licensed Derivative Product Issued by it or which it
Lists on a Licensed Exchange shall be Issued and Listed strictly in accordance with all applicable
legal requirements and without violation of any third party rights. Licensee will defend,
indemnify, and hold harmless RUSSELL and its affiliates, officers, directors, employees, and agents
against any and all claims, demands, actions, suits, or proceedings (including the reasonable costs
of defense inclusive of attorneys’ fees) to the extent arising from a breach of such warranty by
Licensee and asserting that the Issuance, Listing or trading of any Licensed Derivative Product
infringes the Intellectual Property right of any third party, violates applicable legal
requirements, or violates the rights of a third party. The indemnity contained in this Section 11.2
shall not apply to any claims, demands, actions, suits or proceedings to the extent covered by
RUSSELL’s indemnity contained in Section 11.1 hereof.

          11.3 The parties’ obligations under Sections 11.1 and 11.2 shall apply only where (a) the
party seeking indemnification promptly, and within no more than ten (10) business days of its
receipt of notice of a claim, demand, action, suit, or proceeding, gives notice thereof to the
other party; (b) the party seeking indemnification cooperates fully with the other in the defense
thereof (such cooperation does not require and is without waiver by either party of
attorney/client, work product, or other privilege); and (c) the indemnifying party has sole control
of the defense and all related settlement negotiations, provided, however, that the indemnifying
party shall not settle any claim, demand, action, suit or proceeding without the consent
of the indemnified party, which consent shall not be unreasonably withheld.

     12. Limitation of Liability.

     EXCEPT FOR LIABILITY RESULTING FROM RUSSELL’S WILLFUL MISCONDUCT OR GROSS NEGLIGENCE,
LIABILITY UNDER SECTION 11 FOR DAMAGES TO A THIRD PARTY, OR LIABILITY FOR BREACH OF SECTION 16.1,
THE TOTAL AMOUNT OF RUSSELL’S LIABILITY FOR CLAIMS OR LOSSES BASED UPON, ARISING OUT OF, RESULTING
FROM OR IN ANY WAY CONNECTED WITH THIS AGREEMENT OR BREACH OF THIS AGREEMENT, WHETHER BASED UPON
CONTRACT, TORT, WARRANTY, OR OTHERWISE, SHALL IN NO EVENT OR EVENTS EXCEED TWENTY MILLION DOLLARS
($20,000,000). THE ESSENTIAL PURPOSE OF THIS PROVISION IS TO LIMIT RUSSELL’S LIABILITY
UNDER THIS AGREEMENT. LICENSEE UNDERSTANDS AND AGREES THAT THIS LIMITATION REFLECTS A NEGOTIATED
AND REASONABLE ALLOCATION OF RISK GIVEN THE FEES AND THE COMMERCIAL REALITIES OF THE TRANSACTION.

     13. Consequential Damages.

     EXCEPT FOR LIABILITY RESULTING FROM THE WILLFUL MISCONDUCT OR GROSS NEGLIGENCE OF A PARTY
LIABILITY UNDER SECTION 11 FOR DAMAGES TO A THIRD PARTY, OR LIABILITY FOR BREACH OF SECTION
16.1, " NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY, ANY SUBLICENSEE, OR
ANY OTHER PERSON OR ENTITY FOR ANY LOST PROFITS, ANTICIPATED PROFITS, LOSS BY REASON OF SHUTDOWN
IN OPERATION OR INCREASED EXPENSES OF OPERATION, LOSS OF GOODWILL, OR ANY CONSEQUENTIAL,
INCIDENTAL, INDIRECT, PUNITIVE, OR SPECIAL DAMAGES, EVEN IF THE PARTY HAS BEEN ADVISED OF THE
POSSIBILITY OF SUCH DAMAGES.

- 10 -

 

     14. Force Majeure. Notwithstanding any other term or condition of this Agreement,
neither RUSSELL nor Licensee shall be obligated to perform or observe its obligations undertaken
in this Agreement if prevented or hindered from doing so by any circumstances beyond its control,
including, without limitation, acts of God, perils of the sea and air, fire, flood, drought, war,
explosion, sabotage, terrorism, embargo, civil commotion, acts of any governmental body, supplier
delays, communications, or power failure, equipment or software malfunction, and labor disputes.

     15. Trading by RUSSELL Employees. Employees of RUSSELL who are involved in the composition,
computation, method of stock selection or data collection for the Russell US Indexes shall be
expressly prohibited by RUSSELL from trading any Licensed Derivative Product based on a Russell US
Index. RUSSELL shall adopt such reasonable and appropriate procedures as are customary in the
financial services industry to attempt to ensure that neither it, its affiliates nor its employees
shall take advantage of, or communicate to any other person, any knowledge concerning changes in
the composition of the Russell US Indexes before such information is made publicly available, and
to ensure that prior to the time that such information is made publicly available, it shall be
disseminated on a need-to-know basis only or pursuant to RUSSELL’s contractual obligations to its
clients.

     16. Confidentiality.

          16.1 Each party shall treat as confidential and shall not disclose or transmit to any third
party, other than an officer, director or employee of the party who needs to know such information
in order for the party to enter into this contract or fulfill its obligations hereunder, any
documentation or other written materials that are marked as confidential and proprietary by the
providing party (“Confidential Information”). In fulfilling its confidentiality obligations, each
party shall use a reasonable standard of care, at least the same standard of care which it uses to
protect its own similar confidential or proprietary information. The specific terms of this
Agreement shall be treated as Confidential Information. Confidential Information shall not include
(i) any information that is or becomes available to the public or to the receiving party hereunder
from sources other than the providing party (provided that such source is not subject to a
confidentiality agreement with regard to such information) or (ii) any information that is
independently developed by the receiving party without use of or reference to information from the
providing party. Notwithstanding the foregoing, either party may reveal Confidential Information to
any regulatory agency or court of competent country if such information to be disclosed is (a)
approved in writing by the other party for such disclosure or (b) required by law, regulatory
agency or court order to be disclosed by a party, provided, if permitted by law, that prior written
notice of such required disclosure is given to the other party and provided further that the
providing party shall cooperate with the other party to limit the extent of such disclosure. The
provisions of this Section 16 shall survive for a period of five (5) years following the end of the
Term.

          16.2 If and to the extent that Licensee demonstrates to RUSSELL that data underlying the
Russell US Indexes must be submitted by or for Licensee to a governmental regulatory agency, any
commodity self-regulatory organization or to the Intermarket Surveillance Group (“ISG”), for
compliance or surveillance purposes, RUSSELL will make the relevant data available to such agency
or group, provided that the Licensee assists and cooperates with RUSSELL to limit the scope of such
disclosure to the extent permissible and to impose and comply with all protective or similar orders
and confidentiality protections that may be available in the circumstances.

     17. Termination.

          17.1 Either party may elect, without prejudice to any other rights or remedies, to terminate
this Agreement or the Term of any affected Licensed Derivative Product, upon 30 days written notice
if the

- 11 -

 

other party has materially breached this Agreement and fails to cure such breach within such
30-day period.

          17.2 Either party may elect, without prejudice to any other rights or remedies, to terminate
this Agreement or the Term of any affected Licensed Derivative Product without notice, if a
petition in bankruptcy has been filed by (upon 60 days notice with an opportunity to cure within
the stated period if a petition has been filed against the other party), or the other party has
made an assignment for the benefit of creditors, or a receiver has been appointed for the other
party or any substantial portion of other party’s property, or the other party’s or its officers or
directors takes action approving or makes an application for any of the above.

          17.3 RUSSELL may elect, without prejudice to any other rights or remedies, to terminate the
Term of any affected Licensed Derivative Products if RUSSELL reasonably believes that such Licensed
Derivative Product is illegal or has been illegally Issued, or if the Licensee or any Authorized
Trader does not have the power to Issue or to List such Licensed Derivative Products which it has
or is attempting to Issue and/or List, provided that RUSSELL shall not do so without consulting
with Licensee and affording Licensee reasonable opportunity to demonstrate that Licensee has the
power to List and Trade such Licensed Derivative Product.

          17.4 Sections 5 and 6 (each for the sole purpose of the parties’ continuing obligations during
the Closing Period), and sections 7, 9, 10, 11, 12, 13, 14, 16, 18 through 25 of this Agreement
shall survive and continue to bind the parties after the cancellation, termination, or rescission
of this Agreement.

     18. Restrictions on Assignment. Licensee shall not assign, transfer, sublicense or delegate
this Agreement and any rights or obligations hereunder without the other party’s prior written
consent, which shall not be unreasonably withheld or delayed, except that Licensee can assign,
transfer, sublicense or delegate to the Licensed Exchange (including any Exhibit A Affiliate)
provided however that Licensee shall not be relieved of its obligations hereunder. The parties
hereby acknowledge, agree and confirm that they will each give due regard to the value and
importance of the exclusivity provided in this Agreement and the value in allowing the transfer of
each party’s rights and obligations under this Agreement when asked to consent to an assignment,
transfer, sublicense or delegation.

     19. Relationship of the Parties. Nothing in this Agreement, express or implied, is
intended to or shall confer on any person other than the parties hereto, or their respective
permitted successors or assigns, any rights or remedies under or by reason of this Agreement.
The parties are independent contractors under this Agreement and nothing herein or in their
performance hereunder shall constitute either of the parties as a partner or participant in a
joint venture, or as an agent of the other party.

     20. Entire Agreement. This Agreement constitutes the entire agreement between the parties
with respect to the subject matter hereof, and supersedes all prior negotiations, communications,
writings, and understandings.

     21. Governing Law. This Agreement shall be interpreted, construed and enforced in accordance
with the laws of the State of New York, without reference to its principles of conflicts of laws.
Any action, suit or proceeding with respect to any matter arising out of or related to this
Agreement, if commenced by Licensee, shall be commenced in the United States District Court for the
Western District of Washington in Seattle, or, if no federal country exists, then in the Superior
Court of King County, Washington, and if commenced by RUSSELL, shall be commenced in the United
States District Court for the Southern District of New York, or if no federal country exists, then
in the Supreme Court of the State of New York, New York County. Licensee hereby agrees to submit to
the country of such courts and to

- 12 -

 

waive any objections based on venue in any such action, suit or proceeding. No party may bring
any action pertaining to this Agreement more than three years after the event giving rise to such
action has occurred.

     22. Notices. All notices, invoices, and other communications under this Agreement shall be
given in writing (including by facsimile transmission in which an acknowledgement of receipt is
returned electronically) and shall be deemed to have been duly given upon actual receipt by the
parties, or upon constructive receipt if sent by certified mail, return receipt requested (as of
the date of signature or of first refusal of the return receipt), or by such facsimile
transmission. All such notices shall be directed to the respective addresses stated below or to
such other address as any party hereto shall hereafter specify by written notice to the other
party:

	 	 	 	 	 
	 

	 	to Licensee:
	 	Intercontinental-Exchange, Inc.

2100 RiverEdge Parkway, Suite 500

Atlanta, GA 30328

Fax: 770-857-4755

Attn: President, Chief Operating Officer

cc: General Counsel (excluding invoices)
	 
	 	 	 	 
	 

	 	With a copy to
	 	NYBOT

One North End Avenue

New York, NY 10282

Fax: 212-748-4134

Attn: President, Chief Operating Officer

cc: General Counsel
	 
	 	 	 	 
	 

	 	to RUSSELL:
	 	Frank Russell Company

909 A Street

	 

	 	 	 	Tacoma, Washington 98402
	 

	 	 	 	Fax: (253) 272-4097
	 

	 	 	 	Attn: Kelly Haughton
	 

	 	 	 	cc: General Counsel (excluding invoices)

     23. Amendment. Except as otherwise provided herein, no provision of this Agreement may be
amended, modified, or waived, unless by an instrument in writing executed by a duly authorized
officer of the party against whom enforcement of such amendment, modification, or waiver is
sought.

     24. Waiver. No failure on the part of RUSSELL or Licensee to exercise, no delay in
exercising, and no course of dealing with respect to any right, power, or privilege under this
Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such
right, power, or privilege preclude any other or further exercise thereof or the exercise of any
other right, power, or privilege under this Agreement.

     25. Severability. If any of the provisions of this Agreement, or application thereof to any
person or circumstance, shall to any extent be held invalid or unenforceable, the remainder of this
Agreement, or the application of such terms or provisions to persons or circumstances other than
those as to which they are held invalid or unenforceable, shall not be affected thereby and each
such term and provision of this Agreement shall be valid and enforceable to the fullest extent
permitted by law.

     26. HSR Act Filings. Each party and their respective board of directors and employees shall
grant such approvals and take such actions as are necessary so that the Agreement may be
consummated as

- 13 -

 

promptly as practicable on the terms contemplated. Licensee shall pay the filing fees due
under the HSR Act.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date contained in
the signature block for each party below. Each of the persons signing this Agreement affirms
that he or she is duly authorized to do so and thereby binds the indicated entity. This
Agreement may be executed in counterparts, each of which shall be deemed an original, and all of
which together shall constitute one and the same instrument.

	 	 	 	 	 
	FRANK RUSSELL COMPANY

	 	INTERCONTINENTALEXCHANGE, INC.	 	 
	 
	 	 	 	 
	/s/ P. Craig Ueland
 

P. Craig Ueland

	 	/s/ Jeffrey C. Sprecher
 

Jeffrey C. Sprecher
	 	 
	President & Chief Executive Officer

	 	Chairman and Chief Executive Officer	 	 
	Date: June 16, 2007

	 	Date: June 16, 2007	 	 

- 14 -

 

EXHIBIT A

The Licensed Exchange:

Each of Board of Trade of the City of New York, Inc. (a Delaware Corporation) and the
Exhibit A Affiliates identified herein.

     “Exhibit A Affiliates”:

New York Futures Exchange, Inc.

ICE Futures.

Board of Trade of the City of Chicago, Inc. (“CBOT”), if and only if a merger or other
business combination is consummated between Licensee and CBOT Holdings, Inc., resulting
in the establishment and maintenance of a similar affiliate relationship between Licensee
and the CBOT.

Any exchange Licensee owns or controls.

Territory and territorial restrictions:

World wide.

- 15 -

 

EXHIBIT B

The Licensed Derivative Products

Cash settled futures and options on futures on the following Russell US Indexes

Russell 1000® Index

Russell 1000® Growth Index

Russell 1000® Value Index

Russell 2000® Index

Russell 2000® Growth Index

Russell 2000® Value Index

Russell 2500TM Index

Russell 2500TM Growth Index

Russell 2500TM Value Index

Russell 3000® Index

Russell 3000® Growth Index

Russell 3000® Value Index

Russell Midcap® Index

Russell Midcap® Growth Index

Russell Midcap® Value Index

Russell Top 200® Index

Russell Top 200® Growth Index

Russell Top 200® Value Index

Russell Small Cap Completeness® Index

Russell Small Cap Completeness® Growth Index

Russell Small Cap Completeness® Value Index

Russell Top 50® Index

Russell Microcap® Index

Russell Microcap® Growth Index

Russell Microcap® Value Index

Russell 3000ETM Index

- 16 -

 

EXHIBIT C

Licensee Promotional and Marketing Efforts

List and display the Licensed Derivative Products and definitions of the Licensed Derivative
Products prominently on the Licensee’s web site, corporate communications, newsletters, press
releases, and various media sources.

Make reasonable effort to list and display the Licensed Derivative Products on parent company (if
any) and partner web sites and signage.

Develop and hold seminars in support of the Licensed Derivative Products with invitations to
RUSSELL to participate.

Attend and sponsor industry conferences for marketing and sales for the Licensed Derivative
Products.

Develop and provide prominent marketing materials to utilize various external electronic,
television, radio and/or print media sources.

As directed by RUSSELL, use RUSSELL’s logos, names or other registered marks associated with the
Licensed Derivative Product.

- 17 -

 

EXHIBIT D

Fees

	1.	 	Upon the Effective Date of this Agreement, Licensee shall pay RUSSELL a one-time fee of Fifty
Million Dollars ($50,000,000), payable on or before July 1, 2007, in cash or by wire transfer
to an account designated in writing for this purpose by RUSSELL.
	 
	2.	 	Contract Royalties
	 
	 	 	Contract royalties with respect to the first twelve month period following the Effective
Date and with respect to any twelve month period from the Effective Date (if any) during the
Term following 2014 shall be equal to the sum of all contract royalties based on actual
contracts traded, as described below. Contract royalties with respect to each twelve month
period following the first twelve month period following the Effective Date and during the
Initial Term shall be the greater of (i) the minimum set forth below for such period; or
(ii) the sum of all contract royalties based on actual contracts traded. Minimum contract
royalties will be payable by Licensee to RUSSELL quarterly (i.e., in an amount equal to 25%
of the minimum annual contract royalties as set forth in paragraph 3 below); any contract
royalties accruing above the minimum amount shall be reconciled, invoiced and payable within
30 days after the end of the fourth quarter of each one year period.
	 
	 	 	Russell 1000 Index Contract Royalties:

	 	A.	 	With respect to the first 0 to 100,000 contracts:

	 	(i)	 	Each contract traded with a multiplier between one dollar ($1)
and one hundred dollar ($100.00) — $[**] per contract
	 
	 	(ii)	 	Each contract traded with a multiplier between one hundred and
one dollars ($101.00) and five hundred dollar ($500.00) — $[**] per contract
	 
	 	(iii)	 	Each contract traded with a multiplier greater than five
hundred dollars — A ratio of $[**] per $500 per contract (e.g., if the
multiplier is $1,000, the royalty would be $[**] per contract)

	 	B.	 	With respect to the contract 100,001 and above:

	 	(i)	 	Each contract traded with a multiplier between one dollar ($1)
and one hundred dollar ($100.00) — $[**] per contract
	 
	 	(ii)	 	Each contract traded with a multiplier between one hundred and
one dollars ($101.00) and five hundred dollar ($500.00) — $[**] per contract
	 
	 	(iii)	 	Each contract traded with a multiplier greater than five
hundred dollars — A ratio of $[**] per $500 per contract (e.g., if the
multiplier is $1,000, the royalty would be $[**] per contract)

	 	 	All Russell US Indexes Except Russell 1000 Index Contract Royalties:

	 	A.	 	With respect to the first 0 to 100,000 contracts:

	 	(i)	 	Each contract traded with a multiplier between one dollar ($1)
and one hundred dollar ($100.00) — $[**] per contract
	 
	 	(ii)	 	Each contract traded with a multiplier between one hundred and
one dollars ($101.00) and five hundred dollar ($500.00) — $[**] per contract

 

			
	**	 	Certain information on this page has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

- 18 - 

 

	 	(iii)	 	Each contract traded with a multiplier greater than five hundred dollars
 — A ratio of $[**] per $500 per contract (e.g., if the multiplier is $1,000,
the royalty would be $[**] per contract)

	 	B.	 	With respect to the contract 100,001 and above:

	 	(i)	 	Each contract traded with a multiplier between one dollar ($1)
and one hundred dollar ($100.00) — $[**] per contract
	 
	 	(ii)	 	Each contract traded with a multiplier between one hundred and
one dollars ($101.00) and five hundred dollar ($500.00) — $[**] per contract
	 
	 	(iii)	 	Each contract traded with a multiplier greater than five
hundred dollars—A ratio of $[**] per $500 per contract (e.g., if the
multiplier is $1,000, the royalty would be $[**] per contract)

	3.	 	Minimum annual contract royalties (cumulative over all Licensed Derivative Products:

	 	 	 	 	 
	First twelve calendar months following Effective Date:
	 	$	[**]	 
	Next twelve calendar months
	 	 	[**]	 
	Next twelve calendar months
	 	 	[**]	 
	Next twelve calendar months
	 	 	[**]	 
	Next twelve calendar months
	 	 	[**]	 
	Next twelve calendar months
	 	 	[**]	 
	Next twelve calendar months
	 	 	[**]	 

	4.	 	With respect to contracts traded in any twelve month period, the contract royalty rates
stated in paragraph 2 above shall be reduced by a discount of thirty percent (30%) for the
aggregate amount of contracts (if any) traded during a twelve month period in excess of the
volume of trades in that twelve month period required to reach the minimum annual contract
royalties stated in paragraph 3 above for that twelve month period (i.e., if in the first
twelve months following the Effective Date, the aggregate amount of contracts traded results
in payments to RUSSELL of greater than $ [**] (which is the minimum annual contract
royalty), the amount of contract royalties Licensee owes RUSSELL for each contract above the
contract volume that exceeded the payment of $ [**] will be discounted by 30%.

 

			
	**	 	Certain information on this page has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

- 19 -

 

EXHIBIT E

Global Index Licensed Derivative Product Launch

Licensee agrees to use good faith efforts to launch a Licensed Derivative Product on at
least two of the Russell Global Indexes as listed on Russell.com, within 24 months of the
Effective Date of this Agreement pursuant to a separate license agreement for such Licensed
Derivative Product between Russell and Licensee.

-20-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]